Search
Phibro Animal Health Corp
PAHCAdd to Watchlist
33.550USD
-0.550-1.61%
Market hours 09/24, 12:43（ET）
1.36BMarket Cap
14.28P/E TTM
Phibro Animal Health Corp (PAHC) Revenue Performance
Updated: Jun 30, 2026Last year, Phibro Animal Health Corp generated 810.73M USD for its biggest-performing segment, MFAs and Other. The United States made the largest contribution, accounting for 877.13M USD last year. For the latest quarter, Phibro Animal Health Corp reported the revenue of 207.63M USD for the period ending 2026-06-30, which came from the top-performing segment, MFAs and Other. United States contributed the highest revenue, at 220.25M USD.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
MFAs and Other
Nutritional specialties
Vaccines
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
MFAs and Other
810.73M(69.76%)
646.35M(67.13%)
420.96M(59.59%)
387.35M(58.70%)
361.54M(59.56%)
330.02M(60.47%)
322.30M(61.17%)
350.47M(65.88%)
Nutritional specialties
195.07M(16.78%)
179.29M(18.62%)
164.67M(23.31%)
172.50M(26.14%)
157.20M(25.89%)
142.76M(26.16%)
129.26M(24.53%)
113.22M(21.28%)
Vaccines
156.42M(13.46%)
137.15M(14.25%)
120.85M(17.11%)
100.00M(15.15%)
88.32M(14.55%)
72.94M(13.37%)
75.34M(14.30%)
68.29M(12.84%)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
Europe & Middle East & Africa
Asia Pacific
Latin America and Canada
Israel
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
United States
877.13M(57.78%)
739.92M(57.08%)
584.76M(57.46%)
578.77M(59.19%)
561.80M(59.62%)
494.89M(59.39%)
471.94M(58.97%)
480.10M(57.98%)
494.60M(60.32%)
484.15M(63.35%)
473.25M(62.97%)
475.94M(63.58%)
435.41M(62.93%)
414.77M(63.50%)
424.37M(64.88%)
Europe & Middle East & Africa
340.67M(22.44%)
160.23M(12.36%)
121.98M(11.99%)
117.81M(12.05%)
122.48M(13.00%)
114.13M(13.70%)
112.18M(14.02%)
105.36M(12.73%)
43.90M(5.35%)
40.21M(5.26%)
36.18M(4.81%)
36.40M(4.86%)
38.56M(5.57%)
32.50M(4.98%)
30.09M(4.60%)
Asia Pacific
187.94M(12.38%)
97.42M(7.52%)
63.23M(6.21%)
61.45M(6.28%)
66.93M(7.10%)
58.01M(6.96%)
57.30M(7.16%)
90.15M(10.89%)
51.41M(6.27%)
50.48M(6.61%)
46.44M(6.18%)
43.22M(5.77%)
43.42M(6.28%)
44.06M(6.75%)
36.93M(5.65%)
Latin America and Canada
112.36M(7.40%)
298.65M(23.04%)
247.71M(24.34%)
219.85M(22.48%)
191.05M(20.28%)
166.32M(19.96%)
158.94M(19.86%)
152.38M(18.40%)
120.85M(14.74%)
96.69M(12.65%)
105.67M(14.06%)
99.58M(13.30%)
84.78M(12.25%)
68.58M(10.50%)
61.41M(9.39%)
Israel
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
109.22M(13.32%)
92.75M(12.14%)
90.00M(11.98%)
93.46M(12.48%)
89.74M(12.97%)
93.25M(14.28%)
101.30M(15.49%)